New bronchoscopic treatment modalities for patients with chronic bronchitis.
Jorine E HartmanJustin L GarnerPallav L ShahDirk-Jan SlebosPublished in: European respiratory review : an official journal of the European Respiratory Society (2021)
Chronic bronchitis is a chronic, progressive disease that is difficult to treat. Despite much effort, patients remain highly symptomatic. Currently, a number of innovative bronchoscopic treatments for this disease are under investigation. Liquid nitrogen metered cryospray, bronchial rheoplasty and balloon desobstruction all aim to destroy the hyperplastic goblet cells and excess submucous glands using different strategies. These therapies are in an early phase of clinical research and larger randomised controlled trials are needed to confirm the pilot data available and to evaluate the treatment durability. The fourth technique, targeted lung denervation (TLD), aims to decrease the release of acetylcholine, which regulates smooth muscle tone and mucus production by ablating the parasympathetic nerves running alongside the main bronchi. Evaluation of this treatment is at a more advanced stage and promising effects on exacerbation frequency have been shown. However, confirmation of the benefit in improvement in chronic bronchitis symptoms is still needed.
Keyphrases
- end stage renal disease
- clinical trial
- multiple sclerosis
- chronic obstructive pulmonary disease
- chronic kidney disease
- ejection fraction
- combination therapy
- cell death
- electronic health record
- drug delivery
- induced apoptosis
- machine learning
- cancer therapy
- drug induced
- acute respiratory distress syndrome
- data analysis